Oleander Medical Technologies

Oleander Medical Technologies is a pioneering biotechnology company based in Baton Rouge, Louisiana, dedicated to revolutionizing cancer treatment. We are developing Targeted Osmotic Lysis (TOL), a groundbreaking, non-invasive therapy with the potential to destroy cancer cells with minimal damage to healthy tissue. Leveraging decades of research into sodium channel biology, our approach offers a significantly less painful and more cost-effective alternative to traditional methods like radiation and chemotherapy.

We serve patients facing aggressive cancers, offering hope for a future where cancer treatment is both effective and significantly less debilitating. Our team combines expertise in oncology, engineering, and business, driving us toward clinical trials and ultimately, life-changing advancements in cancer care. We are committed to translating scientific breakthroughs into tangible benefits for patients worldwide, and our ongoing patent portfolio reflects our dedication to innovation and protecting our transformative technology.